PATENT CLAIM ANALYSIS

Application Number: 15957625
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "044000"]

Abstract:
A method of treating a T cell-mediated inflammatory autoimmune disease by administering to an individual in need thereof an immunogenic composition comprising a recombinant construct of a nucleic acid sequence encoding heat shock protein 90 (HSP 90), or an active fragment thereof, wherein the nucleic acid sequence is operatively linked to one or more transcription control sequences. The disease is other than insulin dependent diabetes mellitus (IDDM) or rheumatoid arthritis. The administering of the immunogenic composition results in a shift of the immune response to a Th2 response, thereby treating the disease.

Claim (Index 32):
The method of  claim 30 , wherein the inflammatory bowel disease is Crohn's disease.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 91.0
- Lexical Diversity: 1.56923
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15012540', '14507648', '13293722', '12396401', '11813333']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.9045600842841472
- 35 USC 102 Novelty (BERT): 0.6713078573630723
- Combined Prediction Score: 0.8812348615920397
- Mean Citation Score: 797.3803999999999
- Max Citation Score: 894.06055
- Similarity Product: 642.7303995494187

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test